Usage Patterns of Stop Smoking Medications in Four Countries
Author Information
Author(s): Brian V. Fix, Andrew Hyland, Cheryl Rivard, Ann McNeill, Geoffrey T. Fong, Ron Borland, David Hammond, K. Michael Cummings
Primary Institution: Roswell Park Cancer Institute
Hypothesis
How has the introduction of varenicline influenced the usage patterns of stop smoking medications in the US, UK, Canada, and Australia?
Conclusion
The introduction of varenicline led to a significant increase in the use of stop smoking medications among smokers attempting to quit.
Supporting Evidence
- Self-reported use of any stop smoking medication increased significantly over the three-year period.
- Varenicline became the second most used stop smoking medication in all four countries.
- Use rates of varenicline increased dramatically in the US, Canada, and Australia, while uptake in the UK was slower.
Takeaway
This study found that more people are using medications to help them stop smoking, especially a new drug called varenicline, which is helping many smokers quit.
Methodology
Data from the ITC Four Country Survey was analyzed, focusing on smokers who reported a quit attempt in the past year across four countries.
Potential Biases
Potential biases may arise from self-reported data on medication use.
Limitations
The sample size of users for specific medications was relatively small, limiting statistical power for some analyses.
Participant Demographics
Participants included smokers from the US, UK, Canada, and Australia, with variations in demographics such as sex, age, ethnicity, income, and education.
Statistical Information
P-Value
p<0.001
Confidence Interval
95%CI: 0.46–0.80
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website